An ANOCEF Genomic and Transcriptomic Microarray Study of the Response to Irinotecan and Bevacizumab in Recurrent Glioblastomas

Background. We performed a retrospective study to assess whether the initial molecular characteristics of glioblastomas (GBMs) were associated with the response to the bevacizumab/irinotecan chemotherapy regimen given at recurrence. Results. Comparison of the genomic and gene expression profiles of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Laffaire, Julien, Stefano, Anna Luisa Di, Chinot, Olivier, Idbaih, Ahmed, Gallego Perez-Larraya, Jaime, Marie, Yannick, Vintonenko, Nadia, Boisselier, Blandine, Farina, Patrizia, Delattre, Jean-Yves, Figarella-Branger, Dominique, Honnorat, Jérôme, Sanson, Marc, Ducray, François
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2014
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3996912/
https://ncbi.nlm.nih.gov/pubmed/24804210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/282815
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars